CIR 2022 - The 7th Int'l Conference on Inflammation Research (CIR 2022)
View: 105
Website https://novevents.org/conference/CIR2022/ |
Edit Freely
Category Inflammation Research
Deadline: November 05, 2022 | Date: November 25, 2022-November 27, 2022
Venue/Country: Guilin, China, China
Updated: 2022-09-07 10:53:18 (GMT+9)
Call For Papers - CFP
The 7th Int'l Conference on Inflammation Research (CIR 2022) will be held during November 25-27, 2022 in Guilin, China. This Conference will cover issues on Inflammation Research, and other related topics. It dedicates to creating a stage for exchanging the latest research results and sharing the advanced research methods in related fields.Topics of interest include, but are not limited to, the followingAcquired ImmunityAnatomical BarriersAntibody TherapyCancer ImmunotherapyCase StudiesCell Mediated ImmunityCellular ImmunotherapyImmune ResponseImmune System DisordersImmune System ModulatorsImmune TherapyImmunity VitaminsInflammation and Autoimmune DiseasesInflammation and CancerInflammation and Cardiovascular DiseasesInflammation and NeurodegenerationInflammatory DiseasesInhibitory ReceptorsInnate Cancer ImmunologyInnate Immune EvasionInnate ImmunityInnate Molecular ImmunologyMetabolism and InflammationMolecular Patterns and Acute InflammationNew Anti-inflammatory DrugsNitric Oxide, cytokines and InflammationNeural RegulationNovel Mechanisms in InflammationOcular InflammationOsteoarthritis, angiogenesis and inflammationPlant Innate ImmunitySleep and InflammationSuppression ImmunotherapiesTherapeutic ApplicationsOther Related Topics
Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.